A Randomized Controlled Study of Enteral Nutrition in Septic Shock

N/ACompletedNCT02025127

Medical College of Wisconsin31 enrolled

Overview

There is a paucity of data on the timing and role of enteral nutrition in septic shock. The primary aim of this study is to conduct a phase III single-center pilot randomized controlled trial comparing early trophic enteral nutrition to 'no enteral nutrition' in mechanically ventilated septic shock patients to determine feasibility.

Septic shock represents the body's dysregulated response to an infection, manifesting as persistent hypotension (mean arterial pressure \< 70 mmHg) despite intravenous (IV) fluid resuscitation. Severe sepsis and septic shock are major healthcare problems, affecting millions of people around the world each year In critically ill patients without shock, provision of enteral nutrition within 24-48 hours has shown to preserve intestinal epithelium, maintain brush border enzyme activity, maintenance of barrier function to enhance immune function, and preservation of tight cell junctions to reduce permeability. These benefits of enteral nutrition are postulated to prevent downstream complications of nosocomial infections and the multiple organ dysfunction syndrome (MODS), though direct data addressing this question are lacking. The primary aim of this study is to conduct a phase III single-center pilot randomized controlled trial comparing early trophic EN to 'no EN' in mechanically ventilated septic shock patients to determine feasibility of achieving \>75% consent and compliance rate and \<10% contamination rate.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Septic Shock

Interventions

Enteral nutritionOTHER

Enteral nutrition introduced via a feeding tube

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adults greater than or equal to 18 years old * Clinical diagnosis of septic shock * Mechanically ventilation anticipated for at least 48 hours Exclusion Criteria: * Do not resuscitate order * Not able to obtain consent * Those not able to be randomized within 18 hours * Those with small bowel ischemia or obstruction * Protracted ileus, intractable vomiting, major gastrointestinal bleeding defined as needing 2 or more units of packed red cells, and any bowel surgery within the previous 30 days prior to intensive care unit admission * Those with a contraindication for placement of a feeding tube

Locations (1)

Froedtert Hospital

Milwaukee, Wisconsin, United States

Outcomes

Primary Outcomes

number of patients consenting to study and remaining compliant with assigned study arm

consent and compliance rate of \>75% and contamination rate \<10%

Time frame: 46 months

Secondary Outcomes

Ventilator free days

Number of days alive and off mechanical ventilatory support out of 30

Time frame: 30 days

Hospital mortality

number of patients who died during hospitalization

Time frame: 30 days

intensive care unit free days

number of days alive and out of the intensive care unit out of 30

Time frame: 30 days

change in 48 hour sequential organ failure assessment score, with higher score representing worse outcome

absolute change in sequential organ failure assessment score (range 0-24 points) from day 0 to 48 hours, with higher scores representing worse outcomes

Time frame: 48 hours

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.